CS On Sun Pharma
Neutral, TP Rs 450
Cautious Due To Forensic Audit On FY16-18 Financials, Litigation On Ranbaxy Pdts
Margins Can Be High If Cequa Gets A Good Volume Share
Cequa To Help Optimise Ophthalmic Portfolio Spends
Feedback
SUNPHARMA 
Reputation: 13,324 • Oct 15, 2019 1:00 PM
Vote
Comment
Share